Quoin Pharmaceuticals, Ltd.
QNRXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $8.07M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.25$23.50
- Volume (live)
- -
- Avg. volume (3M)
- 40.51K
Quoin Pharmaceuticals (QNRX) Stock Price & Financial Analysis
Quoin Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.02 - $4.08 |
|---|---|
| 52-Week High | $23.50 |
| 52-Week Low | $3.25 |
| Open | $4.08 |
| Volume (last close) | 2.16K |
| Average Volume (3M) | 40.51K |
| 50-Day MA | $5.62 |
|---|---|
| 200-Day MA | $6.39 |
| 1-Year Change | −70.07% |
| Market Cap | 8.07M |
|---|---|
| Shares Outstanding | 2.01M |
| Price to Book (P/B) | 2.05 |
| EV/EBITDA | -0.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Quoin Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Quoin Pharmaceuticals (QNRX) has a market capitalization of $8.07M.
As of its latest reported balance sheet, it holds $3.85M in cash and securities against $0.00 of debt, a net cash position of $3.85M.
Quoin Pharmaceuticals does not currently pay a dividend.
The share price is down 70.1% over the past year. At $4.02 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $3.25 to $23.50, below its 200-day moving average of $6.39.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $22.25, 453.5% above the Oct 23, 2026 close.
Frequently Asked Questions About Quoin Pharmaceuticals
What is the current stock price for QNRX?
As of the Oct 23, 2026 close, QNRX stock trades at $4.02. The 52-week range is $3.25–$23.50, with a day range of $4.02–$4.08.
What is the P/E ratio for QNRX?
The P/E ratio (Price-to-Earnings) for QNRX is shown in the Key Statistics section. This valuation metric helps compare Quoin Pharmaceuticals, Ltd. to industry peers.
Does QNRX pay dividends?
Quoin Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for QNRX?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for QNRX is Buy. The average 12-month price target is $22.25, a 453.5% upside from the Oct 23, 2026 close of $4.02.
What is the market cap of QNRX?
As of the Oct 23, 2026 close, Quoin Pharmaceuticals's market capitalization is $8.1M, classifying it as a micro-cap company. Quoin Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.